“Solu allows us to identify antibiotic resistance patterns in our clinical isolates faster and easier than anything we've used before.”
— Dr. Paul Bollyky
Associate Professor, Stanford University
“Infectious diseases will be one of the major medical challenges in the coming years due to the increasing antimicrobial resistance of bacteria.”
To preserve the effectiveness of antibiotics that have been used for nearly a century, their use must be targeted precisely in the future. Improved understanding of the various resistance mechanisms of antibiotics, along with real-time identification using DNA technologies, will aid in achieving this goal. Solu will play a crucial role in this important advancement in medical diagnostics, and it is truly exciting to be part of this development.
— Prof. Risto Renkonen
Former dean of Helsinki University Faculty of Medicine